AZATHIOPRINE-INDUCED MYELOSUPPRESSION IN THIOPURINE METHYLTRANSFERASE DEFICIENT HEART-TRANSPLANT RECIPIENT

被引：188
|
作者：
SCHUTZ, E [1 ]
GUMMERT, J [1 ]
MOHR, F [1 ]
OELLERICH, M [1 ]
机构：
[1] UNIV GOTTINGEN,DEPT CARDIOTHORAC SURG,W-3400 GOTTINGEN,GERMANY
来源：
LANCET | 1993年 / 341卷 / 8842期
关键词：
D O I：
10.1016/0140-6736(93)93028-Y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：436 / 436
页数：1
相关论文
共 50 条
  • [11] Azathioprine-induced pancytopenia in a patient with pompholyx and deficiency of erythrocyte thiopurine methyltransferase
    Konstantopoulou, M
    Belgi, A
    Griffiths, KD
    Seale, JRC
    Macfarlane, AW
    BRITISH MEDICAL JOURNAL, 2005, 330 (7487): : 350 - 351
  • [12] Azathioprine-induced severe hepatitis in pemphigus foliaceus and thiopurine methyltransferase testing
    Fathallah, N.
    Ben Salem, C.
    Ben Salah, L.
    Slim, R.
    Jeddi, C.
    Belajouza, C.
    Hmouda, H.
    Saguem, S.
    Bouraoui, K.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 81 - 81
  • [13] THIOPURINE S-METHYLTRANSFERASE POLYMORPHISM AS A PREDICTIVE MARKER FOR AZATHIOPRINE-INDUCED HEMATOTOXICITY IN KIDNEY TRANSPLANT RECIPIENTS
    Angsuthum, Susothorn
    Tassaneeyakul, Wichittra
    Pongskul, Cholatip
    Sirivongs, Dhavee
    Tassaneeyakul, Wongwiwat
    Avihingsanon, Yingyos
    Vannaprasaht, Suda
    DRUG METABOLISM REVIEWS, 2007, 39 : 269 - 269
  • [14] Azathioprine-induced severe aplastic anaemia in thiopurine S-methyltransferase deficient patient with Crohn's disease
    Zdziarska, Barbara
    Kurzawski, Mateusz
    Wierzbicka-Paczos, Ewa
    Kozlowska, Anna
    Chosia, Maria
    Pawlik, Andrzej
    Drozdzik, Marek
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 30 (1-2) : 1 - 3
  • [15] Azathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms
    Frohman, EM
    Havrdova, E
    Levinson, B
    Slanar, O
    MULTIPLE SCLEROSIS JOURNAL, 2006, 12 (01) : 108 - 111
  • [16] Normal thiopurine methyltransferase phenotype testing in a Crohn disease patient with azathioprine induced myelosuppression
    Leung, M.
    Piatkov, I.
    Rochester, C.
    Boyages, S. C.
    Leong, R. W. L.
    INTERNAL MEDICINE JOURNAL, 2009, 39 (02) : 121 - 126
  • [17] Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C
    Tassaneeyakul, W
    Srimarthpirom, S
    Reungjui, S
    Chansung, K
    Romphurk, A
    Tassaneeyakul, W
    TRANSPLANTATION, 2003, 76 (01) : 265 - 266
  • [18] REVERSIBLE AZATHIOPRINE-INDUCED ERYTHROCYTE APLASIA IN A RENAL-TRANSPLANT RECIPIENT
    HOGGE, DE
    WILSON, DR
    SHUMAK, KH
    CATTRAN, DC
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1982, 126 (05) : 512 - 513
  • [19] A REVIEW OF AZATHIOPRINE-INDUCED HEPATOTOXICITY AND MYELOSUPPRESSION IN MYASTHENIA GRAVIS
    Jack, K. L.
    Koopman, W. J.
    Hulley, D.
    Nicolle, M. W.
    MUSCLE & NERVE, 2014, 50 (04) : 719 - 719
  • [20] Azathioprine-induced severe bone marrow aplasia due to deficiency of thiopurine S-methyltransferase activity
    Adamek, J.
    Schaich, M.
    Parmentier, S.
    Oncology Research and Treatment, 2015, 38 : 194 - 194
12345